Skip to main content
Book Chapter

Moderna, Pfizer-BioNTech, and Johnson & Johnson/Janssen Post-Covid Vaccine Hematological Adverse Events Including Cerebral Venous Sinus Thrombosis (CVST), Thrombotic Thrombocytopenia (VITT), Blood Clots, Increased Vaginal/Menstrual Bleeding and/or Miscarriage, Stillbirth Delivery, or Premature Birth

Springer Science and Business Media Deutschland GmbH, (2022), 151-160
DOI: 10.1007/978-3-031-04402-1_11
0Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The Centers for Disease Control (CDC) indicated in 2021 that it would monitor for possible post-COVID-19 vaccination coagulopathy adverse events (AEs).

Cite

CITATION STYLE

APA

Champigneulle, O., & Bennett, C. L. (2022). Moderna, Pfizer-BioNTech, and Johnson & Johnson/Janssen Post-Covid Vaccine Hematological Adverse Events Including Cerebral Venous Sinus Thrombosis (CVST), Thrombotic Thrombocytopenia (VITT), Blood Clots, Increased Vaginal/Menstrual Bleeding and/or Miscarriage, Stillbirth Delivery, or Premature Birth. In Cancer Treatment and Research (Vol. 184, pp. 151–160). Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/978-3-031-04402-1_11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free